NVCR NASDAQ
NovoCure Limited
1W: -7.1%
1M: +34.2%
3M: +49.2%
YTD: +29.6%
1Y: -4.9%
3Y: -77.3%
5Y: -90.5%
$17.52
+0.52 (+3.03%)
Weekly Expected Move ±15.9%
$12
$15
$18
$20
$23
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.0B
52W Range9.82-20.06
Volume910,803
Avg Volume1,708,900
Beta0.90
Dividend—
Analyst Ratings
Company Info
CEOFrank Leonard
Employees1,488
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2015-10-01
Websitenovocure.com
No. 4 The Forum
Saint Helier JE2 4UF
JE
Saint Helier JE2 4UF
JE
44 15 3475 6700
About NovoCure Limited
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Latest News
3 Overlooked Stocks Set to Soar in 2026
International Markets and NovoCure (NVCR): A Deep Dive for Investors
NovoCure (NVCR) Q1 2026 Earnings Transcript
Novocure outlines $690M-$710M 2026 revenue guidance as Optune Pax launch reaches 169 prescriptions in 7 weeks
12 Health Care Stocks Moving In Thursday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| VERNON W ANTHONY | M-Exempt | 21,500 | $11.39 | 2026-04-28 |
| VERNON W ANTHONY | M-Exempt | 21,500 | $11.39 | 2026-04-28 |
| Paravasthu Mukund | S-Sale | 43,246 | $13.77 | 2026-03-05 |
| Leupin Nicolas | S-Sale | 1,100 | $13.31 | 2026-03-04 |
| Cordova Ashley | F-InKind | 17,638 | $13.30 | 2026-03-04 |